Primary regulatory
FDA approves Wegovy cardiovascular risk reduction indication
FDA announcement of the cardiovascular risk-reduction indication for Wegovy in eligible adults.
U.S. Food and Drug AdministrationPublished 2024-03-08Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- U.S. Food and Drug Administration
- Source type
- Primary regulatory
- Registry ID
fda-wegovy-cardiovascular-indication-2024
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.